Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

It claims that the PBMs have been rigging pharma supply chain competition in their favour in pursuit of profit, impairing patients' access to lower list price insulin products, and shifting the ...

The suit follows legal action over insulin pricing taken by other states, including Arkansas, Kansas, Mississippi, and Minnesota. "We're fighting back against drug companies and PBMs that ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

As former President Donald Trump has clinched a second term with a victory, his health care priorities will differ somewhat from his first term, ...

GoodRx (NASDAQ:GDRX) is facing lawsuits from several independent pharmacies who are accusing the company of working with pharmacy benefit managers to fix reimbursement fees. The matter is relevant ...

The lawsuits claim that starting in 2023, GoodRx partnered with PBMs to reroute patient prescriptions to whichever PBM offered the lowest price for generics, bypassing the patient's designated PBM.

A campaign led by a diabetes expert at the University of Exeter is aiming reduce plastic waste by encouraging patients and doctors to consider reusable insulin pens. People with diabetes use insulin ...